Sign up
PHVS

Pharvaris BV (NASDAQ: PHVS)

Healthcare · Biotechnology

$31.55−0.73 (−2.26%)

Last close · Nov 18, 2026 · NASDAQ USD

Set alert

The Quantellect read. PHVS fell 2.26% in the Nov 18 session to $31.55, which is 18.8% below its 52-week high of $38.86. Short interest is 5.76% of float with a 0.28% borrow fee. 11 active firms cover the stock as of Nov 18, 2026; 11 active firms with targets average $55.36 over 12 months. Descriptive summary of the data on this page, not a recommendation.

Relative valuationHigher multiples than peers

P/B 7.0× vs peer median 2.6×

MomentumNeutral

RSI (14) 55.0 (overbought above 70, oversold below 30) · as of Nov 17, 2026

TrendBetween the 50- and 200-day averages

$32.28 vs $33.07 and $31.39 · as of Nov 17, 2026

Short interest5.8% of float

FINRA settlement Oct 30, 2026

PHVS price chart

Price $31.55 · As of Nov 18, 2026, 3:59 PM ET

Open full chart →
Nov 17, 2026O $32.00H $32.42L $31.29C $32.28Vol 241K

Chart loads when this section enters view.

Text price and event history
6M plotted price range (ET)
Range6M
First dateMay 18, 2026 ET
Last dateNov 17, 2026 ET
Open$30.21
High$43.25
Low$27.68
Close$32.28
Volume78,886,884
Plotted bars128

Plotted OHLCV bars

  1. May 18, 2026 ET · Open $30.21 · High $30.52 · Low $28.72 · Close $28.81 · Volume 347,438
  2. May 19, 2026 ET · Open $29.19 · High $29.30 · Low $28.33 · Close $28.95 · Volume 301,434
  3. May 20, 2026 ET · Open $29.42 · High $30.21 · Low $29.09 · Close $29.45 · Volume 209,587
  4. May 21, 2026 ET · Open $29.37 · High $30.72 · Low $29.37 · Close $30.54 · Volume 308,788
  5. May 22, 2026 ET · Open $30.57 · High $31.00 · Low $29.51 · Close $29.68 · Volume 291,071
  6. May 26, 2026 ET · Open $30.06 · High $30.61 · Low $29.32 · Close $29.88 · Volume 191,721
  7. May 27, 2026 ET · Open $30.00 · High $30.27 · Low $29.08 · Close $29.47 · Volume 141,851
  8. May 28, 2026 ET · Open $29.76 · High $30.50 · Low $29.43 · Close $29.86 · Volume 254,980
  9. May 29, 2026 ET · Open $29.95 · High $30.35 · Low $29.57 · Close $30.16 · Volume 413,891
  10. Jun 1, 2026 ET · Open $30.00 · High $30.00 · Low $29.02 · Close $29.10 · Volume 143,389
  11. Jun 2, 2026 ET · Open $28.95 · High $29.12 · Low $28.46 · Close $28.98 · Volume 349,742
  12. Jun 3, 2026 ET · Open $28.98 · High $30.50 · Low $28.80 · Close $30.14 · Volume 703,962
  13. Jun 4, 2026 ET · Open $29.99 · High $32.20 · Low $29.56 · Close $31.63 · Volume 361,825
  14. Jun 5, 2026 ET · Open $31.52 · High $31.86 · Low $30.58 · Close $31.09 · Volume 775,069
  15. Jun 8, 2026 ET · Open $31.13 · High $31.83 · Low $30.78 · Close $31.59 · Volume 552,722
  16. Jun 9, 2026 ET · Open $31.65 · High $32.17 · Low $30.27 · Close $31.60 · Volume 465,868
  17. Jun 10, 2026 ET · Open $31.31 · High $32.18 · Low $30.91 · Close $31.51 · Volume 183,665
  18. Jun 11, 2026 ET · Open $31.51 · High $32.46 · Low $31.19 · Close $32.20 · Volume 396,728
  19. Jun 12, 2026 ET · Open $32.33 · High $33.29 · Low $30.60 · Close $30.72 · Volume 180,200
  20. Jun 15, 2026 ET · Open $31.29 · High $31.56 · Low $30.49 · Close $31.54 · Volume 122,963
  21. Jun 16, 2026 ET · Open $31.54 · High $32.28 · Low $30.71 · Close $31.46 · Volume 149,284
  22. Jun 17, 2026 ET · Open $31.46 · High $33.50 · Low $31.38 · Close $33.41 · Volume 287,420
  23. Jun 18, 2026 ET · Open $33.56 · High $34.41 · Low $32.35 · Close $32.80 · Volume 182,167
  24. Jun 22, 2026 ET · Open $33.11 · High $33.97 · Low $32.24 · Close $33.00 · Volume 304,133
  25. Jun 23, 2026 ET · Open $32.95 · High $33.71 · Low $32.06 · Close $33.19 · Volume 326,668
  26. Jun 24, 2026 ET · Open $33.24 · High $34.05 · Low $33.05 · Close $33.29 · Volume 419,462
  27. Jun 25, 2026 ET · Open $33.58 · High $35.33 · Low $33.28 · Close $33.30 · Volume 496,188
  28. Jun 26, 2026 ET · Open $33.53 · High $34.06 · Low $32.93 · Close $34.01 · Volume 519,304
  29. Jun 29, 2026 ET · Open $34.04 · High $35.18 · Low $33.96 · Close $34.71 · Volume 725,457
  30. Jun 30, 2026 ET · Open $34.71 · High $35.91 · Low $33.91 · Close $34.58 · Volume 1,030,953
  31. Jul 1, 2026 ET · Open $34.58 · High $34.58 · Low $33.22 · Close $33.95 · Volume 376,128
  32. Jul 2, 2026 ET · Open $34.37 · High $34.77 · Low $33.16 · Close $33.86 · Volume 478,098
  33. Jul 6, 2026 ET · Open $34.91 · High $34.98 · Low $33.00 · Close $33.22 · Volume 753,087
  34. Jul 7, 2026 ET · Open $33.55 · High $34.74 · Low $33.16 · Close $34.59 · Volume 972,781
  35. Jul 8, 2026 ET · Open $34.59 · High $36.28 · Low $33.85 · Close $35.93 · Volume 950,384
  36. Jul 9, 2026 ET · Open $35.66 · High $36.60 · Low $35.54 · Close $35.96 · Volume 1,887,298
  37. Jul 10, 2026 ET · Open $35.79 · High $36.25 · Low $33.97 · Close $35.07 · Volume 639,305
  38. Jul 13, 2026 ET · Open $34.82 · High $35.18 · Low $33.83 · Close $35.07 · Volume 286,655
  39. Jul 14, 2026 ET · Open $34.89 · High $35.15 · Low $33.96 · Close $34.42 · Volume 283,080
  40. Jul 15, 2026 ET · Open $35.10 · High $35.53 · Low $34.46 · Close $35.16 · Volume 234,436
  41. Jul 16, 2026 ET · Open $35.06 · High $35.18 · Low $33.23 · Close $33.66 · Volume 289,265
  42. Jul 17, 2026 ET · Open $33.29 · High $35.07 · Low $33.24 · Close $34.94 · Volume 236,448
  43. Jul 20, 2026 ET · Open $34.99 · High $35.54 · Low $33.47 · Close $33.55 · Volume 249,421
  44. Jul 21, 2026 ET · Open $33.56 · High $34.65 · Low $33.01 · Close $34.45 · Volume 284,212
  45. Jul 22, 2026 ET · Open $34.66 · High $34.86 · Low $34.04 · Close $34.36 · Volume 283,965
  46. Jul 23, 2026 ET · Open $34.13 · High $34.62 · Low $33.25 · Close $33.26 · Volume 366,232
  47. Jul 24, 2026 ET · Open $33.59 · High $34.38 · Low $33.33 · Close $34.17 · Volume 255,708
  48. Jul 27, 2026 ET · Open $34.17 · High $34.85 · Low $33.84 · Close $33.97 · Volume 213,202
  49. Jul 28, 2026 ET · Open $34.24 · High $34.50 · Low $33.11 · Close $33.65 · Volume 205,062
  50. Jul 29, 2026 ET · Open $33.40 · High $33.85 · Low $32.21 · Close $32.62 · Volume 372,298
  51. Jul 30, 2026 ET · Open $32.62 · High $34.49 · Low $32.62 · Close $33.88 · Volume 512,502
  52. Jul 31, 2026 ET · Open $33.78 · High $33.78 · Low $32.00 · Close $32.62 · Volume 507,255
  53. Aug 3, 2026 ET · Open $32.43 · High $32.82 · Low $31.51 · Close $32.25 · Volume 254,479
  54. Aug 4, 2026 ET · Open $32.75 · High $33.87 · Low $32.59 · Close $33.87 · Volume 253,076
  55. Aug 5, 2026 ET · Open $34.13 · High $34.45 · Low $32.65 · Close $33.42 · Volume 386,924
  56. Aug 6, 2026 ET · Open $33.60 · High $36.02 · Low $33.60 · Close $34.45 · Volume 570,609
  57. Aug 7, 2026 ET · Open $35.00 · High $35.77 · Low $34.45 · Close $34.91 · Volume 696,388
  58. Aug 10, 2026 ET · Open $35.00 · High $35.67 · Low $34.09 · Close $34.84 · Volume 982,000
  59. Aug 11, 2026 ET · Open $34.84 · High $35.13 · Low $33.78 · Close $34.42 · Volume 477,250
  60. Aug 12, 2026 ET · Open $34.03 · High $36.65 · Low $33.00 · Close $36.46 · Volume 1,273,192
  61. Aug 13, 2026 ET · Open $36.50 · High $36.93 · Low $33.79 · Close $34.04 · Volume 738,224
  62. Aug 14, 2026 ET · Open $34.00 · High $36.18 · Low $33.54 · Close $35.14 · Volume 862,899
  63. Aug 17, 2026 ET · Open $34.71 · High $35.61 · Low $34.71 · Close $35.32 · Volume 556,781
  64. Aug 18, 2026 ET · Open $35.35 · High $36.65 · Low $35.08 · Close $36.10 · Volume 609,433
  65. Aug 19, 2026 ET · Open $36.80 · High $36.88 · Low $35.54 · Close $36.27 · Volume 1,042,115
  66. Aug 20, 2026 ET · Open $36.13 · High $36.82 · Low $35.45 · Close $36.39 · Volume 627,797
  67. Aug 21, 2026 ET · Open $36.61 · High $36.93 · Low $36.12 · Close $36.27 · Volume 515,458
  68. Aug 24, 2026 ET · Open $36.27 · High $38.13 · Low $35.70 · Close $37.31 · Volume 691,824
  69. Aug 25, 2026 ET · Open $37.32 · High $38.00 · Low $36.69 · Close $37.23 · Volume 861,175
  70. Aug 26, 2026 ET · Open $37.31 · High $37.40 · Low $36.24 · Close $37.00 · Volume 448,941
  71. Aug 27, 2026 ET · Open $37.00 · High $37.49 · Low $36.30 · Close $37.00 · Volume 765,048
  72. Aug 28, 2026 ET · Open $37.00 · High $37.41 · Low $35.26 · Close $35.32 · Volume 479,029
  73. Aug 31, 2026 ET · Open $35.31 · High $35.73 · Low $34.13 · Close $34.61 · Volume 557,515
  74. Sep 1, 2026 ET · Open $34.45 · High $35.07 · Low $33.80 · Close $34.93 · Volume 394,435
  75. Sep 2, 2026 ET · Open $35.05 · High $35.97 · Low $34.04 · Close $35.17 · Volume 320,876
  76. Sep 3, 2026 ET · Open $35.39 · High $35.88 · Low $34.58 · Close $35.66 · Volume 357,063
  77. Sep 4, 2026 ET · Open $35.36 · High $36.39 · Low $35.21 · Close $35.25 · Volume 483,983
  78. Sep 8, 2026 ET · Open $40.96 · High $43.25 · Low $37.60 · Close $37.84 · Volume 6,328,168
  79. Sep 9, 2026 ET · Open $38.26 · High $39.18 · Low $37.05 · Close $37.74 · Volume 1,427,371
  80. Sep 10, 2026 ET · Open $37.60 · High $39.03 · Low $37.00 · Close $37.51 · Volume 1,324,987
  81. Sep 11, 2026 ET · Open $38.13 · High $40.60 · Low $37.47 · Close $38.02 · Volume 1,449,491
  82. Sep 14, 2026 ET · Open $38.16 · High $40.46 · Low $38.10 · Close $38.86 · Volume 998,004
  83. Sep 15, 2026 ET · Open $39.12 · High $40.00 · Low $37.75 · Close $38.06 · Volume 1,751,144
  84. Sep 16, 2026 ET · Open $38.12 · High $38.38 · Low $37.00 · Close $37.55 · Volume 828,999
  85. Sep 17, 2026 ET · Open $37.81 · High $38.93 · Low $37.60 · Close $38.00 · Volume 1,137,444
  86. Sep 18, 2026 ET · Open $38.09 · High $38.20 · Low $36.08 · Close $36.37 · Volume 580,260
  87. Sep 21, 2026 ET · Open $36.33 · High $36.88 · Low $35.50 · Close $36.02 · Volume 653,735
  88. Sep 22, 2026 ET · Open $35.82 · High $36.27 · Low $34.90 · Close $35.20 · Volume 588,601
  89. Sep 23, 2026 ET · Open $35.19 · High $35.31 · Low $32.87 · Close $33.07 · Volume 654,290
  90. Sep 24, 2026 ET · Open $32.88 · High $33.84 · Low $31.91 · Close $32.99 · Volume 949,002
  91. Sep 25, 2026 ET · Open $33.08 · High $33.62 · Low $31.96 · Close $32.02 · Volume 597,654
  92. Sep 28, 2026 ET · Open $32.00 · High $32.46 · Low $31.39 · Close $31.91 · Volume 753,331
  93. Sep 29, 2026 ET · Open $31.93 · High $32.34 · Low $31.23 · Close $31.73 · Volume 459,293
  94. Sep 30, 2026 ET · Open $31.84 · High $32.05 · Low $31.14 · Close $31.72 · Volume 839,837
  95. Oct 1, 2026 ET · Open $31.74 · High $31.98 · Low $30.90 · Close $31.01 · Volume 654,347
  96. Oct 2, 2026 ET · Open $31.21 · High $31.55 · Low $30.69 · Close $31.19 · Volume 591,391
  97. Oct 5, 2026 ET · Open $31.19 · High $31.47 · Low $30.15 · Close $30.49 · Volume 816,234
  98. Oct 6, 2026 ET · Open $30.50 · High $31.27 · Low $30.15 · Close $31.12 · Volume 778,389
  99. Oct 7, 2026 ET · Open $30.97 · High $32.32 · Low $30.58 · Close $31.68 · Volume 341,842
  100. Oct 8, 2026 ET · Open $31.57 · High $31.57 · Low $30.30 · Close $31.12 · Volume 628,231
  101. Oct 9, 2026 ET · Open $31.14 · High $31.96 · Low $31.09 · Close $31.10 · Volume 754,990
  102. Oct 12, 2026 ET · Open $31.09 · High $31.93 · Low $30.64 · Close $30.89 · Volume 646,018
  103. Oct 13, 2026 ET · Open $30.68 · High $31.21 · Low $29.99 · Close $30.02 · Volume 443,982
  104. Oct 14, 2026 ET · Open $30.00 · High $30.52 · Low $29.80 · Close $30.02 · Volume 400,428
  105. Oct 15, 2026 ET · Open $30.20 · High $30.85 · Low $29.23 · Close $29.64 · Volume 820,425
  106. Oct 16, 2026 ET · Open $29.50 · High $29.54 · Low $27.68 · Close $27.74 · Volume 1,307,641
  107. Oct 19, 2026 ET · Open $27.80 · High $29.95 · Low $27.80 · Close $29.77 · Volume 917,081
  108. Oct 20, 2026 ET · Open $29.83 · High $31.60 · Low $29.83 · Close $30.90 · Volume 1,029,035
  109. Oct 21, 2026 ET · Open $31.22 · High $31.50 · Low $30.55 · Close $30.66 · Volume 393,583
  110. Oct 22, 2026 ET · Open $30.76 · High $31.02 · Low $29.84 · Close $30.68 · Volume 347,236
  111. Oct 23, 2026 ET · Open $31.57 · High $32.12 · Low $30.25 · Close $31.41 · Volume 621,710
  112. Oct 26, 2026 ET · Open $31.38 · High $32.08 · Low $31.30 · Close $31.54 · Volume 347,676
  113. Oct 27, 2026 ET · Open $31.62 · High $32.34 · Low $31.59 · Close $31.95 · Volume 230,115
  114. Oct 28, 2026 ET · Open $31.79 · High $32.86 · Low $31.74 · Close $32.82 · Volume 381,074
  115. Oct 29, 2026 ET · Open $32.84 · High $33.62 · Low $32.70 · Close $33.58 · Volume 877,867
  116. Oct 30, 2026 ET · Open $33.48 · High $33.94 · Low $33.05 · Close $33.53 · Volume 1,481,527
  117. Nov 2, 2026 ET · Open $33.68 · High $34.21 · Low $32.90 · Close $33.53 · Volume 633,056
  118. Nov 3, 2026 ET · Open $33.90 · High $35.30 · Low $33.90 · Close $34.78 · Volume 577,201
  119. Nov 4, 2026 ET · Open $35.06 · High $35.42 · Low $33.03 · Close $34.33 · Volume 311,377
  120. Nov 5, 2026 ET · Open $34.33 · High $34.66 · Low $32.53 · Close $32.53 · Volume 932,848
  121. Nov 6, 2026 ET · Open $32.85 · High $35.21 · Low $32.28 · Close $34.39 · Volume 405,107
  122. Nov 9, 2026 ET · Open $34.80 · High $35.47 · Low $34.05 · Close $34.47 · Volume 638,333
  123. Nov 10, 2026 ET · Open $34.10 · High $35.05 · Low $33.21 · Close $33.99 · Volume 745,421
  124. Nov 11, 2026 ET · Open $34.01 · High $34.73 · Low $33.82 · Close $34.18 · Volume 421,746
  125. Nov 12, 2026 ET · Open $33.59 · High $34.55 · Low $33.00 · Close $33.83 · Volume 376,268
  126. Nov 13, 2026 ET · Open $33.79 · High $34.28 · Low $32.85 · Close $33.36 · Volume 182,643
  127. Nov 16, 2026 ET · Open $33.19 · High $34.46 · Low $32.44 · Close $32.44 · Volume 307,782
  128. Nov 17, 2026 ET · Open $32.00 · High $32.42 · Low $31.29 · Close $32.28 · Volume 241,403

Event records

Event records load after the price chart.

Split-adjusted daily prices · Price as of Nov 17, 2026, 8:51 PM ET

Initial 6M price range summary
Range6M
First close$28.81
Last close$32.28
High$43.25
Low$27.68
Volume78,886,884
Open
$32.24Nov 18, 2026 session
Previous close
$32.28Nov 17, 2026 close
Day range
$31.22 – $32.63Nov 18, 2026 session
52-week range
$23.68 – $38.86Through Nov 18, 2026
Volume
390.16KNov 18, 2026 session
Average volume (30 calendar days, 22 sessions)
563.64KThrough Nov 18, 2026
Market cap$2.35B
P/E (TTM)negative earnings —
Forward P/E—
EPS (TTM)stale vendor snapshot —
Dividend yielddata unavailable —
Beta (5-year monthly vs SPY)−2.44

Price history

PHVS · nasdaq · USD

Last completed session: Nov 17, 2026

Split-adjusted · volume in shares

Missing session: Nov 18, 2026

November 2026 · 12 completed sessions
DateOpenHighLowCloseChangeVolume
32.0032.4231.2932.28−0.16−0.493218%241,403
Open 32.00High 32.42Low 31.29
33.1934.4632.4432.44−0.92−2.757794%307,782
Open 33.19High 34.46Low 32.44
33.7934.277832.8533.36−0.47−1.389299%182,643
Open 33.79High 34.2778Low 32.85
33.5934.54533.0033.83−0.35−1.023991%376,268
Open 33.59High 34.545Low 33.00
34.0134.72533.81534.18+0.19+0.558988%421,746
Open 34.01High 34.725Low 33.815
34.1035.0533.2133.99−0.48−1.392515%745,421
Open 34.10High 35.05Low 33.21
34.8035.4734.0534.47+0.08+0.232626%638,333
Open 34.80High 35.47Low 34.05
32.8535.2132.27934.39+1.86+5.717799%405,107
Open 32.85High 35.21Low 32.279
34.3334.6632.5332.53−1.80−5.243227%932,848
Open 34.33High 34.66Low 32.53
35.0635.41533.0334.33−0.45−1.293847%311,377
Open 35.06High 35.415Low 33.03
33.9035.3033.9034.78+1.25+3.728005%577,201
Open 33.90High 35.30Low 33.90
33.6834.2132.9033.530.000.00%633,056
Open 33.68High 34.21Low 32.90

Notable price movement

Sessions where the close moved at least twice its average daily move of the prior 20 sessions (minimum 3%), or 10% or more.

  1. $34.39+5.72%

    Trading volume was 0.6 times the 30-day average, with 405.11K shares traded.

  2. $32.53−5.24%

    Trading volume was 1.4 times the 30-day average, with 932.85K shares traded.

  3. $29.77+7.32%

    Trading volume was 1.3 times the 30-day average, with 917.08K shares traded.

Options flow

— · Options flow not available

Q Score

55/100Moderate

Latest available: Nov 13, 2026 · updates irregularly

Each axis is a 0 to 100 percentile rank among equities

Liquidity58Short39Squeeze35Trend61Momentum63Valuation50Stability57
What each one means
  • Liquidity58

    Higher scores reflect greater average dollar trading volume and less absolute return per dollar traded over 21 sessions within equity peers.

  • Short39

    Higher scores reflect less short-interest pressure relative to trading volume and the company's own history, and less growth in shares short, within equity peers.

  • Squeeze35

    Higher scores reflect a higher published Squeeze score within equity peers.

  • Trend61

    Higher scores reflect a price nearer its 252-session split-adjusted closing high and positive 63- and 126-session total returns.

  • Momentum63

    Higher scores reflect stronger 63- and 126-session total returns within equity peers.

  • Valuation50

    Higher scores reflect lower positive P/E, P/B, EV/EBITDA and price/sales multiples within equity peers; limited data pulls the score toward neutral.

  • Stability57

    Higher scores reflect lower daily total-return volatility over 63 and 252 sessions within equity peers.

How the Q Score works →

Quantellect signals

Change since Nov 18

Insufficient data · Tide session Nov 18, 2026

Tide36Calm Tide—
Squeeze21Idle—
How the scores work →

How PHVS compares with its industry

Against 592 other US-listed Biotechnology stocks

Dot = rank among peers, low to high · tick = peer median · colour marks the top and bottom 10%

Strongest points

  1. One-month return was 8.4%, higher than 82% of 567 peers.Peer median −10.3% · As of Nov 16, 2026

Points of caution

  1. Trailing-year net margin was 0%, with only 19% of 583 peers reporting a lower value.Peer median 0.0% · As of Nov 17, 2026

Valuation

Higher multiples than peers

  • Price/sales—13.88×

    Not ranked: only 408 of 592 peers report it

  • Forward P/E—14.90×

    Not ranked: only 194 of 592 peers report it

  • Price/book7.03×2.57×

    Higher than 79% of 551 peers

Profitability

Profitability metrics are lower than most peers.

  • Gross margin—78.4%

    Not ranked: only 247 of 592 peers report it

  • Operating margin0.0%0.0%

    Higher than 26% of 442 peers

  • Net margin0.0%0.0%

    Higher than 19% of 583 peers

  • Return on equity−70.5%−67.8%

    Higher than 48% of 554 peers

Growth

Growth metrics are lower than most peers.

  • Quarterly sales growth, year over year0.0%0.0%

    Higher than 32% of 592 peers

  • 5-year sales growth rate—11.3%

    Not ranked: only 140 of 592 peers report it

Balance sheet

Not enough peers report balance sheet metrics for a group comparison.

  • Current ratio—5.01

    Not ranked: only 499 of 592 peers report it

  • Debt/equity (total borrowings)—0.23

    Not ranked: only 117 of 592 peers report it

Momentum

Returns are higher than most peers.

  • 1-year return+37.1%−29.8%

    Higher than 81% of 522 peers

  • 6-month return+11.5%−24.0%

    Higher than 75% of 547 peers

  • 3-month return−11.0%−31.7%

    Higher than 77% of 559 peers

Compared with 592 other US-listed Biotechnology stocks · fundamentals as of Nov 1, 2026 · prices as of Nov 12, 2026

Upcoming events

— · Upcoming events not available

Analyst consensus

Buy

0Strong Buy
10Buy
1Neutral
0Sell
0Strong Sell

Based on 11 active firms as of Nov 18, 2026 (365-day activity window)

12-month price targets (third-party analysts)

Low$30.00
Average$55.36
High$79.00

As of Nov 18, 2026 across 11 active firms with targets. Targets are published by third-party analysts, not by Quantellect.

Full analyst forecast →

Earnings history

— · Earnings history not available

Smart-money activity

In the last 60 days: 3 insider sales and 0 purchases. Last quarter: 0 new 13F positions. No congressional trades in 90 days.

DateTypeWhoActionAmountSource
Insider sellMonges VivianeSell$395.5KForm 4
Insider sellSchikan Johannes Gerardus Christiaan PetrusSell$29.0KForm 4
Insider sellNassif David W.Sell$218.8KForm 4
Insider sellLu PengSell$3.5MForm 4
Insider sellSchikan Johannes Gerardus Christiaan PetrusSell$7MForm 4
Insider sellBjork ElisabethSell$2.0MForm 4
Insider sellGlassman RobertSell$558.8KForm 4
Insider sellLesage AnneSell$765.5KForm 4
Insider sellAbele Stefan AndreasSell$54.9KForm 4
Insider sellAbele Stefan AndreasSell$1.7MForm 4
All smart-money activity →

News and press releases

All PHVS news →

Company profile

Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases. The company develops deucrictibant, a small molecule bradykinin B2-receptor antagonist to treat attacks due to bradykinin-mediated angioedema, including hereditary angioedema (HAE) and acquired angioedema due to C1-inhibitor deficiency (AAE-C1INH), which is in phase 3, as well as in

CEO
Mr. Berndt Axel Edvard Modig CPA, M.B.A.
Headquarters
Zug, Switzerland
Employees
148
IPO date
Feb 5, 2021
Sector
Healthcare
Industry
Biotechnology

Data sources: exchange quotes delayed 15 minutes, FINRA short interest, SEC filings, OPRA options data and third-party analyst data. Education only. Nothing on this page is a recommendation to buy or sell a security.